Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Chabannon, C
167  Ergebnisse:
Personensuche X
?
1

Activity of ex vivo graft and DLI Engineering within the la..:

de Witte, M. A. ; Mooyaart, J. E. ; Hoogenboom, J. D....
Bone Marrow Transplantation.  58 (2023)  6 - p. 719-722 , 2023
Link: https://doi.org/10.1038/..
 
?
2

Fresh or frozen grafts for allogeneic stem cell transplanta..:

Worel, N. ; Ljungman, P. ; Verheggen, I. C. M....
Bone Marrow Transplantation.  58 (2023)  12 - p. 1348-1356 , 2023
Link: https://doi.org/10.1038/..
 
?
3

Management of adults and children receiving CAR T-cell ther..:

Hayden, P.J. ; Roddie, C. ; Bader, P....
Annals of Oncology.  33 (2022)  3 - p. 259-275 , 2022
Link: https://doi.org/10.1016/..
 
?
4

P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AN..:

Basak, G. ; Peczynski, C. ; Koenecke, C....
HemaSphere.  6 (2022)  - p. 1327-1328 , 2022
Link: https://doi.org/10.1097/..
 
?
5

The first steps towards a diverse and inclusive EBMT: a pos..:

Montoto, S. ; Snowden, J. A. ; Chabannon, C....
Bone Marrow Transplantation.  57 (2022)  3 - p. 343-346 , 2022
Link: https://doi.org/10.1038/..
 
?
6

P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTI..:

Dachy, F. ; Furst, S. ; Calmels, B....
HemaSphere.  6 (2022)  - p. 1214-1215 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P1332: PROMISING OUTCOME OF PATIENTS OLDER THAN 70 YEARS WH..:

Harbi, S. ; Brac de la perriere, L. ; Garciaz, S....
HemaSphere.  6 (2022)  - p. 1217-1218 , 2022
Link: https://doi.org/10.1097/..
 
?
8

Immunothérapie des cancers au troisième millénaire 

La cancérologie aujourd'hui
Zitvogel, Laurence ; Adotevi, Olivier ; Amigorena, Sebastian... , [2021]
Link: https://www.degruyter.co..
 
?
9

Related versus unrelated allogeneic HPC graft cryopreservat..:

Mfarrej, B. ; Lemarié, C. ; Granata, A....
Bone Marrow Transplantation.  56 (2021)  8 - p. 2013-2015 , 2021
Link: https://doi.org/10.1038/..
 
?
10

Mobilization regimen, including Plerixafor, does not impact..:

Kerjean, E.M. ; Velier, M. ; Mfarrej, B....
Cytotherapy.  22 (2020)  5 - p. S147 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Validation of a flow cytometry-based method for quantitativ..:

Mfarrej, B. ; Gaude, J. ; Couquiaud, J....
Cytotherapy.  22 (2020)  5 - p. S155 , 2020
Link: https://doi.org/10.1016/..
 
?
12

CAR-T cells : lymphocytes exprimant un récepteur chimérique..:

Chabannon, C. ; Bouabdallah, R. ; Fürst, S....
La Revue de Médecine Interne.  40 (2019)  8 - p. 545-552 , 2019
Link: https://doi.org/10.1016/..
 
?
13

IMPACT OF CLASS II HLA MISMATCH ON CLINICAL OUTCOMES IN HOD..:

Castagna, L. ; Bramanti, S. ; Devillier, R....
Hematological Oncology.  37 (2019)  S2 - p. 300-301 , 2019
Link: https://doi.org/10.1002/..
 
?
14

Development of adaptive immune effector therapies in solid ..:

Comoli, P. ; Chabannon, C. ; Koehl, U....
Annals of Oncology.  30 (2019)  11 - p. 1740-1750 , 2019
Link: https://doi.org/10.1093/..
 
?
15

CHECKPOINT INHIBITION BEFORE HAPLOIDENTICAL TRANSPLANTATION..:

de Philippis, C. ; Legrande, F. ; Bramanti, S....
Hematological Oncology.  37 (2019)  S2 - p. 298-299 , 2019
Link: https://doi.org/10.1002/..
 
1-15